Artificial Intelligence in Trapeziometacarpal Joint Osteoarthritis: Improving Assessment and Clinical Decision-Making
TMCAI
1 other identifier
observational
2,500
1 country
1
Brief Summary
This is a retrospective cohort study utilizing radiographic and computed tomography (CT) imaging data collected during routine clinical care at Schulthess Klinik Zürich. The study focuses on developing and validating artificial intelligence (AI)-based tools for the assessment of trapeziometacarpal (TMC) joint osteoarthritis (OA) and implant monitoring. The project is divided into four subprojects: (1) development of a new radiographic classification system for TMC OA, (2) automation of the classification using deep learning, (3) automated detection of implant migration, and (4) 3-dimensional (3D) reconstruction of the TMC joint from biplanar radiographs. Data will be sourced from two cohorts: patients from our clinical TMC arthroplasty registry who received the Touch implant, and patients with other wrist-related conditions who underwent radiographic imaging with a visible TMC joint. Together, these cohorts provide a broad coverage across the full spectrum of OA severity. OA-related features and implant related features will serve as the foundation for model training and validation. Also, they will be validated with CT images regarding reliability and accuracy. The resulting prototypes for automated OA staging, implant migration detection, and 3D modeling of the TMC joint are exclusively used for research purposes. Any future clinical use of these tools, including evaluation under Swissmedic (Swiss Agency for Therapeutic Products) regulations, will be part of a separate project.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2025
CompletedFirst Posted
Study publicly available on registry
August 29, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
April 30, 2026
April 1, 2026
2.9 years
August 21, 2025
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
New TMC OA classification
Create a novel classification system for TMC OA based on joint and bone features in X-rays. This system should ensure better reliability, accurately reflect joint health, and provide clinically relevant insights for treatment decisions.
Preoperative
Automation of the new TMC OA classification
Implement a deep learning-based system to automate TMC joint OA classification in plain radiographs using convolutional neural networks for segmentation and feature extraction. This approach aims to improve consistency and reduce the need for manual annotations.
Preoperative
Automated implant migration detection
Develop an AI-based system for detecting implant loosening and migration in postoperative radiographs, for early detection of loosening and long-term monitoring of implant stability.
Postoperative
3D reconstruction of the TMC joint
Create a 3D reconstruction of the trapezium and the first metacarpal from biplanar radiographs. This provides advanced insights into individual trapezium geometry to improve surgical planning.
Preoperative
Study Arms (2)
Osteoarthritis
Patients in our TMC arthroplasty registry (Business Administration System for Ethics Committees (BASEC) number: 2019-02096): Patients who received a Touch implant for TMC joint arthroplasty. Data will be included in the study from the creation of the registry in 2018 until the end of January 2028.
Healthy
Patients with other clinical conditions leading to TMC joint radiography.
Interventions
No Intervention: Observational Cohort
Eligibility Criteria
The study population consists of patients treated at Schulthess Klinik Zürich with available radiographic imaging of the TMC joint. Data are derived from two cohorts: (1) patients enrolled in the TMC arthroplasty registry (BASEC number: 2019-02096) who received a Touch implant since 2018, and (2) patients with other wrist-related conditions requiring radiographs in which the TMC joint is clearly visible. The combined cohorts provide a balanced representation across the spectrum of TMC joint OA severity, from healthy joints to end-stage disease.
You may qualify if:
- Patients will be included in the study if they have provided written general consent for the use of their clinical data and meet the requirements of one of the following two groups:
- TMC OA group:
- Patients who received a Touch implant for TMC joint arthroplasty and are documented in our clinical registry
- Other clinical conditions:
- Patients who underwent radiographic imaging for one of the following conditions, with a clearly visible TMC joint, for example: Distal radius fracture, carpal fracture, finger dislocation, or similar.
You may not qualify if:
- TMC OA group:
- Patients with posttraumatic OA.
- Patients with rheumatoid arthritis.
- Other clinical conditions:
- Eaton Littler score higher than one.
- Prior surgery affecting the trapezium or the first metacarpal.
- Clinical condition resulting in abnormal TMC joint morphology.
- Furthermore, patients will also be excluded if they revoke their consent in writing or via verbal withdrawal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Schulthess Kliniklead
- ETH Zurich (Switzerland)collaborator
Study Sites (1)
Schulthess Klinik
Zurich, Canton of Zurich, 8008, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2025
First Posted
August 29, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared. The study involves sensitive clinical data that is subject to privacy protections and institutional regulations. Ownership of the data remains with the clinic, and confidentiality requirements prevent making these data publicly available.